|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Interest-bearing time deposits | ||||||||||||||||||||
| Available-for-sale-securities (Note 2) | ||||||||||||||||||||
| Stock in FHLB | ||||||||||||||||||||
| Stock in Federal Reserve Bank of St. Louis | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans receivable, net of ACL of $54,912 and $51,629 at June 30, 2026 and June 30, 2025, respectively (Note 3) | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Premises and equipment, net (Note 4) | ||||||||||||||||||||
| Bank owned life insurance - cash surrender value | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Deposits (Note 5) | ||||||||||||||||||||
| Securities sold under agreements to repurchase (Note 6) | ||||||||||||||||||||
| Advances from FHLB (Note 7) | ||||||||||||||||||||
| Accounts payable and other liabilities | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Subordinated debt (Note 8) | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Common stock, $.01 par value; 25,000,000 shares authorized; 12,009,617 and 11,980,887 shares issued at June 30, 2026 and June 30, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock of 998,508 and 681,420 shares at June 30, 2026 and June 30, 2025, respectively, at cost | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| TOTAL STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
Loading...
